Passage Bio, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes (NCT04747431) | Passage Bio, Inc. | 2021-09-14 |
Track Passage Bio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.